BCHE and dementia: As reported in some recent studies, FDG PET could help differentiate the underlying pathology in patients with CBS.24, 25In patients with “atypical/unclear dementia,” an FDG PET scan led to a diagnostic change in 59.5% of the cases, and it increased the prescription of cholinesterase inhibitors from 13.8 to 38.3%.26